Journal of Pharmaceutical Policy and Practice
[Accessed 14 Sep 2019]
| 11 September 2019
Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 “Fake Drug Crisis” acted as a driving force to reform the regulatory structures of the country and for establishing the autonomous “Drug Regulatory Authority of Pakistan”. Despite the fact that Pakistan possesses a huge pharmaceutical industry, there is a severe dearth of published literature and scientific evidence for the country regarding medicine quality and the prevalence of counterfeit and low-quality products, respectively.
Authors: Huma Rasheed, Ludwig Hoellein, Khalid Saeed Bukhari and Ulrike Holzgrabe